164 filings
Page 3 of 9
EFFECT
rt88pd7oakk 2oh2y
17 Jul 23
Notice of effectiveness
12:15am
6-K
lf5zqkm1x6eqwm zw
14 Jul 23
Immunoprecise Antibodies LTD. 6-K
8:10am
CORRESP
3n8s5c
13 Jul 23
Correspondence with SEC
12:00am
UPLOAD
t56lae
12 Jul 23
Letter from SEC
12:00am
F-3
w08 elmorsum50rz0eiw
10 Jul 23
Shelf registration (foreign)
7:04pm
40-F
630a gw7avcctgt4bmkb
10 Jul 23
Annual report (Canada)
4:32pm
SC 13D
6b3vy
7 Jul 23
ImmunoPrecise Antibodies / INGALLS & SNYDER ownership change
3:22pm
6-K
bb678 0atmx4jib
7 Jul 23
Immunoprecise Antibodies LTD. 6-K
8:36am
6-K
ofea4sb5yiup
29 Jun 23
The Company to host an earnings conference call via webcast
9:01am
6-K
ljlmsskc
13 Jun 23
Immunoprecise Antibodies LTD. 6-K
7:41am
6-K
rx65noi 3t2
6 Jun 23
Immunoprecise Antibodies LTD. 6-K
8:09am
6-K
is5a1bdiyalnxk qv
30 May 23
Immunoprecise Antibodies LTD. 6-K
8:04am
6-K
hayimi13k3cxrpc
17 May 23
Immunoprecise Antibodies LTD. 6-K
11:35am
6-K
my89fej8
24 Apr 23
Current report (foreign)
10:01am
6-K
ji3c78xx3
30 Mar 23
Form 51-102F3 MATERIAL CHANGE REPORT
12:53pm
6-K
alhy3rdo xbo
30 Mar 23
Immunoprecise Antibodies LTD. 6-K
8:04am
6-K
hyvkj0ymuk78fvzvkz
27 Mar 23
Immunoprecise Antibodies LTD. 6-K
9:05am
6-K
fqkexxy37ite y4
23 Mar 23
Immunoprecise Antibodies LTD. 6-K
8:19am
6-K
z9kz37 os20osksnl1
16 Mar 23
Immunoprecise Antibodies LTD. 6-K
8:08am
6-K
dezsii6h2pnnu
16 Mar 23
Current report (foreign)
8:00am